Glenmark Generics receives ANDA approval for Rizatriptan Benzoate Orally Disintegrating Tablets

02 Jul 2013 Evaluate

Glenmark Generics Inc, USA, the United States subsidiary of Glenmark Generics has received a final approval from United States Food and Drug Administration (US FDA) Rizatriptan Benzoate Orally Disintegrating Tablets, its generic version of Merck’s Maxalt MLT Tablets. The company will commence shipping immediately.

The approval is for the 5 mg and 10 mg of Rizatriptan ODT. According to IMS Health for the 12 month period ending March 2013, Rizatriptan ODT achieved sales of $ 263 million.

Glenmark’s current portfolio consists of 87 products authorized for distribution in the U.S. marketplace and 53, ANDA's pending approval with the U.S. FDA. In addition to these internal filings, GGI continues to identify and explore external development partnerships to supplement and accelerate the growth of the existing pipeline and portfolio.

Glenmark Pharma Share Price

1985.35 11.30 (0.57%)
15-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1280.40
Cipla 1507.25
Zydus Lifesciences 921.25
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×